Literature DB >> 25331104

Comparative pharmacology and toxicology of pharmaceuticals in the environment: diphenhydramine protection of diazinon toxicity in Danio rerio but not Daphnia magna.

Lauren A Kristofco1, Bowen Du, C Kevin Chambliss, Jason P Berninger, Bryan W Brooks.   

Abstract

Pharmaceuticals and other contaminants of emerging concern present unique challenges to environmental risk assessment and management. Fortunately, mammalian pharmacology and toxicology safety data are more readily available for pharmaceuticals than other environmental contaminants. Identifying approaches to read-across such pharmaceutical safety information to non-target species represents a major research need to assess environmental hazards. Here, we tested a biological read-across hypothesis from emergency medicine with common aquatic invertebrate and vertebrate models. In mammals, the antihistamine diphenhydramine (DPH) confers protection from poisoning by acetylcholinesterase inhibition because DPH blocks the acetylcholine receptor. We employed standardized toxicity methods to examine individual and mixture toxicity of DPH and the acetylcholinesterase inhibitor diazinon (DZN) in Daphnia magna (an invertebrate) and Danio rerio (zebrafish, a vertebrate). Though the standardized Fish Embryo Toxicity method evaluates early life stage toxicity of zebrafish (0-3 days post fertilization, dpf), we further evaluated DPH, DZN, and their equipotent mixture during three development stages (0-3, 3-6, 7-10 dpf) in zebrafish embryos. Independent action and concentration addition mixture models and fish plasma modeling were used to assist interpretation of mixture toxicity experiments. Though our primary hypothesis was not confirmed in acute studies with Daphnia magna, DPH conferred a protective effect for acute DZN toxicity to zebrafish when DPH plasma levels were expected to be greater than mammalian therapeutic, but lower than acutely lethal, internal doses. We further observed that timing of developmental exposure influenced the magnitude of DZN and DPH toxicity to zebrafish, which suggests that future zebrafish toxicity studies with pharmaceuticals and pesticides should examine exposure during developmental stages.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25331104      PMCID: PMC4287288          DOI: 10.1208/s12248-014-9677-5

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  48 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

2.  Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals.

Authors:  Jason P Berninger; Bryan W Brooks
Journal:  Toxicol Lett       Date:  2009-12-16       Impact factor: 4.372

Review 3.  Predictive environmental risk assessment of chemical mixtures: a conceptual framework.

Authors:  Thomas Backhaus; Michael Faust
Journal:  Environ Sci Technol       Date:  2012-02-22       Impact factor: 9.028

Review 4.  Fish on Prozac (and Zoloft): ten years later.

Authors:  Bryan W Brooks
Journal:  Aquat Toxicol       Date:  2014-01-19       Impact factor: 4.964

5.  Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior.

Authors:  Nina Peitsaro; Maria Sundvik; Oleg V Anichtchik; Jan Kaslin; Pertti Panula
Journal:  Biochem Pharmacol       Date:  2007-01-12       Impact factor: 5.858

6.  Assessment of toxicity reduction in wastewater effluent flowing through a treatment wetland using Pimephales promelas, Ceriodaphnia dubia, and Vibrio fischeri.

Authors:  J M Hemming; P K Turner; B W Brooks; W T Waller; T W La Point
Journal:  Arch Environ Contam Toxicol       Date:  2002-01       Impact factor: 2.804

7.  Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna.

Authors:  Edward M Dzialowski; Philip K Turner; Bryan W Brooks
Journal:  Arch Environ Contam Toxicol       Date:  2006-03-31       Impact factor: 2.804

Review 8.  Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data.

Authors:  James P Laurenson; Raanan A Bloom; Stephen Page; Nakissa Sadrieh
Journal:  AAPS J       Date:  2014-01-28       Impact factor: 4.009

9.  Correction of organophosphate-induced neuromuscular blockade by diphenhydramine.

Authors:  R M Clemmons; D J Meyer; S F Sundlof; J J Rappaport; M E Fossler; J Hubbell; M R Dorsey-Lee
Journal:  Am J Vet Res       Date:  1984-10       Impact factor: 1.156

10.  Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish.

Authors:  Jared V Goldstone; Andrew G McArthur; Akira Kubota; Juliano Zanette; Thiago Parente; Maria E Jönsson; David R Nelson; John J Stegeman
Journal:  BMC Genomics       Date:  2010-11-18       Impact factor: 3.969

View more
  3 in total

1.  Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine.

Authors:  Lauren A Kristofco; Luis Colon Cruz; Samuel P Haddad; Martine L Behra; C Kevin Chambliss; Bryan W Brooks
Journal:  Aquat Toxicol       Date:  2015-09-25       Impact factor: 4.964

2.  Mitigation of diazinon-induced cardiovascular and renal dysfunction by gallic acid.

Authors:  Temitayo Olabisi Ajibade; Ademola Adetokunbo Oyagbemi; Temidayo Olutayo Omobowale; Ebunoluwa Racheal Asenuga; Jeremiah Moyinoluwa Afolabi; Adeolu Alex Adedapo
Journal:  Interdiscip Toxicol       Date:  2017-05-17

3.  Urbanization, environment and pharmaceuticals: advancing comparative physiology, pharmacology and toxicology.

Authors:  Bryan W Brooks
Journal:  Conserv Physiol       Date:  2018-01-17       Impact factor: 3.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.